期刊文献+

急性药物性肝损伤患者肝病相关抗体阳性率调查及其临床意义 被引量:1

Prevalence of liver disease-related antibodies in patients with acute drug-induced liver injury and its clinical significance
下载PDF
导出
摘要 目的:分析急性药物性肝损伤患者肝病相关抗体阳性情况。方法复习2002年6月~2012年3月大连医科大学附属第一医院住院患者中诊断为急性药物性肝损伤患者的资料,分析肝病相关抗体的阳性情况。结果104例患者中肝病相关抗体阳性率为54.81%,其中ANA 45.19%,ASMA 14.42%;ANA高滴度(≥1:320)的患者占ANA阳性患者的34.04%;2种抗体同时阳性的占阳性患者的26.32%,以ANA和ASMA阳性最常见;3种抗体同时阳性的占阳性患者的8.77%,以ANA/AMA/AMA-M2同时阳性多见;女性患者抗体阳性率高于男性,肝细胞损伤型患者抗体阳性率高于胆汁淤积型和混合型患者(P<0.05)。结论急性药物性肝损伤患者肝病相关抗体的阳性率高达一半以上,尤其是女性、肝细胞损伤型患者,应注意鉴别。 Objective To explore the prevalence of serial autoimmune antibody associated with liver dis-eases in patients with acute drug-induced liver injury (ADILI). Methods A retrospective analysis was conducted over 104 patients with ADILI,admitted to the First Affiliated Hospital of Dalian Medical University from June 2002 to March 2012,and the prevalence of liver disease-related autoimmune antibody were analyzed. Results The positive rate of liver disease-related autoantibodies in 104 cases was 54.81%;Among the positive patients ,ANA was positive in 47 cases (45.19%) and ASMA in 15 cases (14.42%);The high ANA titer (≥1:320) accounted for 34.04% in ANA-positive cases;Two antibodies positive accounted for 26.32% in 57 antibody-positive cases, and ANA/ASMA was the most common;Serum ANA/AMA/AMA-M2 positive accounted for 8.77% in 57 antibody-positive cases;Female had higher antibody positive rate than male did,and the antibody positive rate was higher in patients with hepatocellular injury pattern than those in cholestatic or mixed pattern. Conclusions The preva-lence of liver disease-related antibodies was positive in more than half the patients with ADILI,especially common in females and cases of hepatocellular injury pattern. Clinician should keep an open eye on differential diagnosis.
作者 卢丹 段志军
出处 《实用肝脏病杂志》 CAS 2015年第5期504-507,共4页 Journal of Practical Hepatology
关键词 药物性肝损伤 肝病相关抗体 阳性率 Drug-induced liver injury Liver disease-related antibodies Prevalence
  • 相关文献

参考文献20

  • 1许建明.急性药物性肝损伤诊治建议(草案)[J].中华消化杂志,2007,27(11):765-767. 被引量:349
  • 2厉有名.药物性肝损害的临床类型及诊断策略[J].中华肝脏病杂志,2004,12(7):445-446. 被引量:252
  • 3陈慧,郑聘聘,王炳元.药物诱发自身免疫性肝炎的研究进展[J].传染病信息,2011,24(5):313-318. 被引量:13
  • 4Lueena MI, Kaplowitz N, Hallal H,et al. Recurrent drug - induced liver injury(DILl) with different drugs in the Spanish Registry:the dilemma of the relationship to autoimmunehepatitis. J Hepatol,2011,55(4):820-827.
  • 5Pena-lnan A. Drug-induced liver injury caused by simvastatin associated with antinuelear antibodies. Med Clin (Bare),2015, 144(4):189-190.
  • 6Aliberti S,Grignani G,Allione P,et al. An acute hepatitis resembling autoimmune hepatitis occurring during imatinib therapy in a gastrointestinal stromal tumor patient. Am J Clin Oneol, 2009,32 (6):640-641.
  • 7Ramakrishna J,Johnson AR,Banner BF. Long-term minoeyeline for acne in healthy adolescents can cause severe autoimmune hepatitis. J Clin Gastroenterol,2009,43(8):787-790.
  • 8Leise MD,Poterueha JJ,Talwalkar JA. Drug-induced liver injury. Mayo Clin Proc,2014,89(1):95-106.
  • 9Hayashi M,Kanda T1,Nakamura M,et al. Acute liver injury in a patient with alcohol dependenee:a ease resembling autoimmune hepatitis or drug-indueedliver injury. Case Rep Gastroenterol, 2014,8(1):129-133.
  • 10Faa G,Ekstrom J,Castagnola M,et al. A developmental approach to drug-induced liver injury in newborns and children. Curr Med Chem, 2012,19(27):4581-4594.

二级参考文献157

  • 1仲人前,屠小卿.自身免疫性肝炎的病因和发病机理[J].临床肝胆病杂志,2004,20(5):260-263. 被引量:8
  • 2周毅,杨旭,刘桃成,刘凤娥.中老年自身免疫性肝炎重叠综合征14例临床分析[J].临床内科杂志,2006,23(9):617-619. 被引量:1
  • 3李蕴铷,魏来,王文冰,王培之,张黎颖,欧蔚妮,谢雯,成军.自身免疫性肝炎临床、免疫学及病理学特征分析142例[J].世界华人消化杂志,2006,14(36):3534-3538. 被引量:12
  • 4冼永超,吴洛琳.自身免疫性肝炎的临床诊断研究状况[J].华夏医学,2007,20(4):878-880. 被引量:3
  • 5Joshi S, Cauch-Dudek K, Wallless IR, et al. Primary biliary cirrhosis with additional features of autoimmune hepatitis:response to therapy with ursodeoxycholic acid [J].Hepatology ,2002 ;35 (2) :409-13.
  • 6Chazouilleres O,Wendum D, Senfaty L,et al. Long term outcome and response to therapy of primary biliary cirrhosis-autoimmune hepatitis overlap syndrome[J].J Hepatol,2006 ;44(2 ) :400-6.
  • 7Alvarez F, Berg PA, Blanchi FB,et al. International Autoimmune Hepatitis Group Report: review of criteria for diagnosis of autoimmune hepatitis [J]. J Hepato,1999;31(5) :929-38.
  • 8Wiegard C, Schramm C, Lohse AM. Scoring systems for the diagnosis of autoimmune hepatitis : past, present, and future[J]. Semin Liver Dis, 2009 ;29 (3) :254-61.
  • 9Lohse AW, Mieli-Vergani G. Autoimmune hepatitis[J]. J Hepatol, 2011, 55(1):171-182.
  • 10Czaja AJ. Drug-induced autoimmune-like hepatitis [J]. Dig Dis Sci, 2011, 56(4):958-976.

共引文献639

同被引文献15

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部